StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)

Equities research analysts at StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSVGet Rating) in a research report issued on Friday. The brokerage set a “hold” rating on the stock.

Several other equities analysts also recently weighed in on OBSV. HC Wainwright downgraded ObsEva from a “buy” rating to a “neutral” rating in a research report on Tuesday, August 30th. Canaccord Genuity Group lowered ObsEva from a “buy” rating to a “hold” rating and cut their price objective for the company from $12.00 to $1.00 in a research report on Monday, August 1st. Finally, Cantor Fitzgerald lowered ObsEva from an “overweight” rating to a “neutral” rating in a research report on Thursday, July 28th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $8.40.

ObsEva Stock Performance

Shares of OBSV stock opened at $0.18 on Friday. The company has a market cap of $13.75 million, a price-to-earnings ratio of -0.23 and a beta of 0.46. The stock has a 50 day simple moving average of $0.17 and a 200-day simple moving average of $0.80. ObsEva has a 12-month low of $0.13 and a 12-month high of $2.45. The company has a current ratio of 2.98, a quick ratio of 2.98 and a debt-to-equity ratio of 1.18.

Institutional Trading of ObsEva

Large investors have recently added to or reduced their stakes in the company. Two Sigma Investments LP purchased a new position in shares of ObsEva during the 3rd quarter valued at $25,000. Pictet Asset Management SA raised its position in shares of ObsEva by 25.8% during the third quarter. Pictet Asset Management SA now owns 371,595 shares of the company’s stock valued at $53,000 after buying an additional 76,196 shares during the last quarter. Credit Suisse AG raised its position in ObsEva by 8.7% in the third quarter. Credit Suisse AG now owns 1,577,118 shares of the company’s stock worth $224,000 after purchasing an additional 126,812 shares in the last quarter. Millennium Management LLC acquired a new position in ObsEva in the second quarter worth about $192,000. Finally, Virtu Financial LLC increased its holdings in shares of ObsEva by 434.2% during the second quarter. Virtu Financial LLC now owns 104,951 shares of the company’s stock worth $169,000 after buying an additional 85,303 shares in the last quarter. 20.12% of the stock is owned by institutional investors and hedge funds.

About ObsEva

(Get Rating)

ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.

Further Reading

Analyst Recommendations for ObsEva (NASDAQ:OBSV)

Receive News & Ratings for ObsEva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ObsEva and related companies with MarketBeat.com's FREE daily email newsletter.